Glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, is highly expressed in certain types of tumor, including lung cancer, breast carcinoma and RCC 7-9. This evidence concerns the gene G6PD and lung carcinoma.